Based on the key measurements obtained from Smith Nephew's financial statements, Smith Nephew SNATS is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April. At this time, Smith Nephew's Accounts Payable is very stable compared to the past year. As of the 22nd of March 2025, Cash is likely to grow to about 650 M, while Other Current Liabilities is likely to drop about 146.3 M. Key indicators impacting Smith Nephew's financial strength include:
The essential information of the day-to-day investment outlook for Smith Nephew includes many different criteria found on its balance sheet. An individual investor should monitor Smith Nephew's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Smith Nephew.
Smith Nephew competes with CochLear, Integer Holdings, Orthofix Medical, Glaukos Corp, and Bruker. Smith Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. Smith Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom. Smith Nephew operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 18000 people.
Comparative valuation techniques use various fundamental indicators to help in determining Smith Nephew's current stock value. Our valuation model uses many indicators to compare Smith Nephew value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Smith Nephew competition to find correlations between indicators driving Smith Nephew's intrinsic value. More Info.
Smith Nephew SNATS is rated second in return on equity category among its peers. It is currently regarded as top stock in return on asset category among its peers reporting about 0.69 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Smith Nephew SNATS is roughly 1.44 . At this time, Smith Nephew's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Smith Nephew's earnings, one of the primary drivers of an investment's value.
Smith Nephew SNATS Systematic Risk
Smith Nephew's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Smith Nephew volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Smith Nephew SNATS correlated with the market. If Beta is less than 0 Smith Nephew generally moves in the opposite direction as compared to the market. If Smith Nephew Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Smith Nephew SNATS is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Smith Nephew is generally in the same direction as the market. If Beta > 1 Smith Nephew moves generally in the same direction as, but more than the movement of the benchmark.
Smith Nephew Thematic Clasifications
Smith Nephew SNATS is part of Obamacare Repeal investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Large healthcare related equities associated with Obamacare. Healthcare and drug manufacturing companies that will most likely be affected by the final stages of Obamacare repeal
This theme covers Large healthcare related equities associated with Obamacare. Healthcare and drug manufacturing companies that will most likely be affected by the final stages of Obamacare repeal. Get More Thematic Ideas
Today, most investors in Smith Nephew Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Smith Nephew's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Smith Nephew growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Smith Nephew help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Smith Nephew SNATS. We use our internally-developed statistical techniques to arrive at the intrinsic value of Smith Nephew SNATS based on widely used predictive technical indicators. In general, we focus on analyzing Smith Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Smith Nephew's daily price indicators and compare them against related drivers.
When determining whether Smith Nephew SNATS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Smith Nephew's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Smith Nephew Snats Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Smith Nephew Snats Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Smith Nephew SNATS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Smith Nephew. If investors know Smith will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Smith Nephew listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.164
Dividend Share
0.375
Earnings Share
0.94
Revenue Per Share
2.662
Quarterly Revenue Growth
0.06
The market value of Smith Nephew SNATS is measured differently than its book value, which is the value of Smith that is recorded on the company's balance sheet. Investors also form their own opinion of Smith Nephew's value that differs from its market value or its book value, called intrinsic value, which is Smith Nephew's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Smith Nephew's market value can be influenced by many factors that don't directly affect Smith Nephew's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Smith Nephew's value and its price as these two are different measures arrived at by different means. Investors typically determine if Smith Nephew is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Smith Nephew's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.